Everlab Raises AU$65M Series A

Everlab, a Melbourne, Australia-based healthtech company that provides a data-driven, AI-enabled platform for preventative healthcare, has raised AU$65 million in a Series A funding round.

Investors

The round was led by Airtree Ventures, with participation from global investors including Plural, as well as existing investors Left Lane Capital and b2venture. The round also saw participation from angel investor and Australian Test captain Pat Cummins.

Everlab Use of Funds

Everlab plans to use the new capital to strengthen its clinical and technology infrastructure and accelerate its global rollout, beginning with an expansion into the United Kingdom.

About Everlab

Founded in 2023 by Dr. Steven Lu, Sam Kothari, Anshul Jain, and Marc Hermann, Everlab provides a digital platform that organizes diagnostics, doctor consultations, specialist coordination, prescriptions, and continuous AI-driven care in one place. The company aims to shift the primary care system from treating illness to preventative health, helping users maximize their healthspan.

Funding Details

Company Website: https://everlab.com.au

Company: Everlab
Raised: AU$65M
Round: Series A
Funding Date: June 16, 2026
Lead Investor: Airtree Ventures
Additional Investors: Plural, Left Lane Capital, b2venture, Pat Cummins
Company Website: www.everlab.com.au
Software Category: Healthtech
Source: https://www.businesswire.com/news/home/20260616811872/en/Everlab-Raises-AU%2465m-Series-A-to-Make-World-Class-Preventative-Healthcare-Something-Everyone-Can-Access